Cognitive Measures Lacking in EHR Prior to Dementia or Alzheimer's Disease Diagnosis

Overview

Journal Alzheimers Dement

Specialties Neurology
Psychiatry

Date 2021 Mar 3

PMID 33656251

Citations 11

Authors

Nancy Maserejian

Henry Krzywy

Susan Eaton

James E Galvin

Affiliations

Soon will be listed here.

Abstract

Introduction: The extent that cognitive measures are documented in electronic health records (EHR) is important for quality care and addressing disparities in timely diagnosis of dementia or Alzheimer's disease (AD).

Methods: Analysis of U.S. EHR data to describe the frequency and factors associated with cognitive measures prior to diagnosis of dementia (N = 111,125) or AD (N = 30,203).

Results: Only 11% of dementia patients and 24% of AD patients had a cognitive measure documented in the 5 years prior to diagnosis. Black race, older age, non-commercial health insurance, lower mean neighborhood income, greater in-patient stays, and fewer out-patient visits were associated with lacking cognitive measures.

Discussion: Extensive missing cognitive data and differences in the availability of cognitive measures by race, age, and socioeconomic factors hinder patient care and limit utility of EHR for dementia research. Structured fields and prompts for cognitive data inputs at the point of care may help address these gaps.

Citing Articles

Real-World Insights Into Dementia Diagnosis Trajectory and Clinical Practice Patterns Unveiled by Natural Language Processing: Development and Usability Study.

Paek H, Fortinsky R, Lee K, Huang L, Maghaydah Y, Kuchel G JMIR Aging. 2025; 8:e65221.

PMID: 39999185 PMC: 11878476. DOI: 10.2196/65221.

Natural language processing in Alzheimer's disease research: Systematic review of methods, data, and efficacy.

Shakeri A, Farmanbar M Alzheimers Dement (Amst). 2025; 17(1):e70082.

PMID: 39935888 PMC: 11812127. DOI: 10.1002/dad2.70082.

Detection and Diagnosis of Early Symptomatic Alzheimer's Disease in Primary Care.

Cabral D, Obisesan T Fed Pract. 2025; 41(Suppl 6):S7-S12.

PMID: 39839066 PMC: 11745466. DOI: 10.12788/fp.0530.

Distinct medical and substance use histories associate with cognitive decline in Alzheimer's Disease.

Mansel C, Mazzotti D, Townley R, Sardiu M, Swerdlow R, Honea R medRxiv. 2024; .

PMID: 39649607 PMC: 11623748. DOI: 10.1101/2024.11.26.24317918.

Cognitive Impairment and Dementia in Atrial Fibrillation: A Population Study of 4.3 Million Individuals.

Chung S, Rossor M, Torralbo A, Ytsma C, Fitzpatrick N, Denaxas S JACC Adv. 2024; 2(9):100655.

PMID: 38938718 PMC: 11198352. DOI: 10.1016/j.jacadv.2023.100655.

References

Petersen R, Yaffe K . Issues and Questions Surrounding Screening for Cognitive Impairment in Older Patients. JAMA. 2020; 323(8):722-724. PMC: 7263399. DOI: 10.1001/jama.2019.22527. View

van Walraven C, Austin P, Jennings A, Quan H, Forster A . A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009; 47(6):626-33. DOI: 10.1097/MLR.0b013e31819432e5. View

Cordell C, Borson S, Boustani M, Chodosh J, Reuben D, Verghese J . Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimers Dement. 2012; 9(2):141-50. DOI: 10.1016/j.jalz.2012.09.011. View

Wilkinson T, Ly A, Schnier C, Rannikmae K, Bush K, Brayne C . Identifying dementia cases with routinely collected health data: A systematic review. Alzheimers Dement. 2018; 14(8):1038-1051. PMC: 6105076. DOI: 10.1016/j.jalz.2018.02.016. View

Barnes D, Zhou J, Walker R, Larson E, Lee S, Boscardin W . Development and Validation of eRADAR: A Tool Using EHR Data to Detect Unrecognized Dementia. J Am Geriatr Soc. 2019; 68(1):103-111. PMC: 7094818. DOI: 10.1111/jgs.16182. View

Chen Y, Tysinger B, Crimmins E, Zissimopoulos J . Analysis of dementia in the US population using Medicare claims: Insights from linked survey and administrative claims data. Alzheimers Dement (N Y). 2019; 5:197-207. PMC: 6556828. DOI: 10.1016/j.trci.2019.04.003. View

Nori V, Hane C, Crown W, Au R, Burke W, Sanghavi D . Machine learning models to predict onset of dementia: A label learning approach. Alzheimers Dement (N Y). 2019; 5:918-925. PMC: 6920083. DOI: 10.1016/j.trci.2019.10.006. View

Maserejian N, Krzywy H, Eaton S, Galvin J . Cognitive measures lacking in EHR prior to dementia or Alzheimer's disease diagnosis. Alzheimers Dement. 2021; 17(7):1231-1243. PMC: 8359414. DOI: 10.1002/alz.12280. View

Benjamin R . Assessing risk, automating racism. Science. 2019; 366(6464):421-422. DOI: 10.1126/science.aaz3873. View

10.

Pippenger M, Holloway R, Vickrey B . Neurologists' use of ICD-9CM codes for dementia. Neurology. 2001; 56(9):1206-9. DOI: 10.1212/wnl.56.9.1206. View

11.

Savva G, Arthur A . Who has undiagnosed dementia? A cross-sectional analysis of participants of the Aging, Demographics and Memory Study. Age Ageing. 2015; 44(4):642-7. PMC: 4560041. DOI: 10.1093/ageing/afv020. View

12.

Knopman D, Gottesman R, Sharrett A, Wruck L, Windham B, Coker L . Mild Cognitive Impairment and Dementia Prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). Alzheimers Dement (Amst). 2016; 2:1-11. PMC: 4772876. DOI: 10.1016/j.dadm.2015.12.002. View

13.

Clark P, Kutner N, Goldstein F, Peterson-Hazen S, Garner V, Zhang R . Impediments to timely diagnosis of Alzheimer's disease in African Americans. J Am Geriatr Soc. 2005; 53(11):2012-7. DOI: 10.1111/j.1532-5415.2005.53569.x. View

14.

Owens D, Davidson K, Krist A, Barry M, Cabana M, Caughey A . Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020; 323(8):757-763. DOI: 10.1001/jama.2020.0435. View

15.

McCoy Jr T, Han L, Pellegrini A, Tanzi R, Berretta S, Perlis R . Stratifying risk for dementia onset using large-scale electronic health record data: A retrospective cohort study. Alzheimers Dement. 2019; 16(3):531-540. PMC: 7067642. DOI: 10.1016/j.jalz.2019.09.084. View

16.

Galvin J, Tolea M, Chrisphonte S . What older adults do with the results of dementia screening programs. PLoS One. 2020; 15(7):e0235534. PMC: 7329076. DOI: 10.1371/journal.pone.0235534. View

17.

Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A . Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 2000; 54(11):2072-7. DOI: 10.1212/wnl.54.11.2072. View

18.

Steenland K, Goldstein F, Levey A, Wharton W . A Meta-Analysis of Alzheimer's Disease Incidence and Prevalence Comparing African-Americans and Caucasians. J Alzheimers Dis. 2015; 50(1):71-6. PMC: 4739787. DOI: 10.3233/JAD-150778. View

19.

Cohen B, D Donofrio P . Coding for Dementia. Continuum (Minneap Minn). 2016; 22(2 Dementia):626-36. DOI: 10.1212/CON.0000000000000308. View

20.

Barnes L, Bennett D . Alzheimer's disease in African Americans: risk factors and challenges for the future. Health Aff (Millwood). 2014; 33(4):580-6. PMC: 4084964. DOI: 10.1377/hlthaff.2013.1353. View